Reply to: "Comment on Kridin et al. - Considering Both Relative and Absolute Risk Differences in Infection Risk Between Biologics Classes in Patients With Psoriasis".
Khalaf KridinHenner ZirpelNoor MruwatRalf J LudwigDiamant ThaciPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Keyphrases